Accessibility Menu
 
Cresco Labs logo

Cresco Labs

(OTC) CRLBF

Current Price$1.09
Market Cap$392.44M
Since IPO (2018)-75%
5 Year-92%
1 Year+20%
1 Month+19%

Cresco Labs Financials at a Glance

Market Cap

$392.44M

Revenue (TTM)

$658.33M

Net Income (TTM)

$138.14M

EPS (TTM)

$-0.38

P/E Ratio

-2.88

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$1.09

Volume

718,220

Open

$1.08

Previous Close

$1.09

Daily Range

$1.05 - $1.14

52-Week Range

$0.43 - $2.30

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cresco Labs

Industry

Pharmaceuticals

Employees

2,900

CEO

Charles Bachtell

Headquarters

Chicago, IL 60654, US

CRLBF Financials

Key Financial Metrics (TTM)

Gross Margin

49%

Operating Margin

10%

Net Income Margin

-21%

Return on Equity

-33%

Return on Capital

6%

Return on Assets

-12%

Earnings Yield

-34.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$392.44M

Shares Outstanding

360.03M

Volume

718.22K

Avg. Volume

1.06M

Financials (TTM)

Gross Profit

$309.72M

Operating Income

$78.46M

EBITDA

$128.03M

Operating Cash Flow

$74.17M

Capital Expenditure

$35.75M

Free Cash Flow

$38.41M

Cash & ST Invst.

$90.92M

Total Debt

$583.10M

Cresco Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$164.04M

-6.0%

Gross Profit

$79.56M

-3.6%

Gross Margin

48.50%

N/A

Market Cap

$392.44M

N/A

Market Cap/Employee

$135.32K

N/A

Employees

2,900

N/A

Net Income

$90.32M

-1965.8%

EBITDA

$29.12M

-10.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$492.18M

+2.0%

Accounts Receivable

$38.94M

-24.5%

Inventory

$0.00

-100.0%

Long Term Debt

$560.09M

-9.1%

Short Term Debt

$23.06M

-2.1%

Return on Assets

-11.56%

N/A

Return on Invested Capital

6.00%

N/A

Free Cash Flow

$18.72M

-28.0%

Operating Cash Flow

$27.88M

-5.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NWBONorthwest Biotherapeutics, Inc.
$0.20+0.00%
PTCHFPureTech Health plc
$1.92+13.81%
VRNOFVerano Holdings Corp.
$1.30+8.33%
KHTRFKnight Therapeutics Inc.
$5.40+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$50.22-0.03%

Questions About CRLBF

What is the current price of Cresco Labs?

Cresco Labs is trading at $1.09 per share.

What is the 52-week range for Cresco Labs?

Over the past 52 weeks, Cresco Labs has traded between $0.43 and $2.30.

How much debt does Cresco Labs have?

As of the most recent reporting period, Cresco Labs reported total debt of $584.16M.

How much cash does Cresco Labs have on hand?

Cresco Labs reported $91.09M in cash and cash equivalents in its most recent financial results.

What is Cresco Labs’s dividend yield?

Cresco Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.